TOBINintel · Condition

Insulin Resistance (Prediabetes Pattern)

Insulin resistance means the body needs more insulin to keep glucose normal. It often comes years before type 2 diabetes. It is estimated with HOMA-IR = (fasting insulin µIU/mL × fasting glucose mg/dL) ÷ 405. Values of about 2.5 or more, a triglyceride/HDL ratio of 3 or more, or HbA1c of 5.7–6.4% suggest it. HOMA-IR cutoffs vary by population and assay, so it guides risk but does not diagnose.

Key points

Gut microbiome composition associates with insulin sensitivity; microbiome treatments remain investigational.
Test to discuss: Fasting glucose and fasting insulin → HOMA-IR
Test to discuss: HbA1c
Test to discuss: Triglycerides and HDL → TG/HDL ratio
Test to discuss: Waist circumference and waist-to-height ratio (≥ 0.5)
Test to discuss: ALT (fatty liver often co-exists)
150+ minutes of activity weekly plus resistance training
7% weight loss where overweight (DPP)
7–9 hours of sleep
Limit refined carbohydrates and sugary drinks

Root-cause chain

Visceral adiposity → Hepatic and muscle insulin resistanceA

B · Established causal · Free-fatty-acid flux and adipokines impair insulin signalling; weight loss reverses it (DPP).

Physical inactivity → Reduced glucose uptake by muscleA

O · Randomized evidence · Exercise increases GLUT4 translocation independent of insulin.

Short or poor sleep → Lower insulin sensitivityB

O · Randomized evidence · Sleep restriction trials reduce insulin sensitivity within days.

Endocrine-active chemicals (BPA, phthalates) → Insulin resistanceD

T · Exposure signal · NHANES associations and animal data; causation in humans is not established.

Protocols by lane

Evidence grade + regulatory status

Conventional: Metformin for high-risk prediabetes (BMI ≥ 35, age < 60, prior gestational diabetes)A

DPP: metformin cut progression to diabetes by 31%; ADA recommends considering it in these groups.

Status: Off-label · Cautions: B12 deficiency with long use; avoid with low kidney function (eGFR < 30).

Functional: Intensive lifestyle program: 7% weight loss and 150 min/week activityA

DPP: 58% fewer progressions to diabetes; effect lasting at 15 years.

Status: Lifestyle · Cautions: Adapt to heart and joint limits.

Integrative: Resistance training 2–3 sessions per weekA

Improves insulin sensitivity in meta-analyses.

Status: Lifestyle · Cautions: Progress gradually.

Orthomolecular: Correct measured vitamin D deficiencyC

D2d trial: no significant overall diabetes prevention; correct only true deficiency.

Status: Supplement · Cautions: Monitor calcium with high doses.

Traditional: Mediterranean dietary patternB

PREDIMED: lower diabetes incidence.

Status: Lifestyle · Cautions: Watch energy intake from oils and nuts.

Energy / Physical: No energy modality improves insulin resistanceE

Listed for completeness only.

Status: Investigational · Cautions: Must not be presented as a treatment.

Monitoring

HbA1c and fasting glucose every 6–12 months
HOMA-IR or fasting insulin trend
Waist and weight trend
TOBIN score change over time

Go deeper

Full condition page →Library: formulas & sources →All TOBINintel entries

iDetection of an exposure does not establish that it caused a disease. This platform separates exposure, association, plausible mechanism, clinical evidence and demonstrated causation.